Ann: Medlab to Expand Nutraceutical Range into 2,100 Pharmacies, page-7

Thanks @DrKnow. Can I ask where you got that table from or is it something you are privately tracking?? Additional to that list are also EVE, ESE that I am aware of.
If not too much to ask would you be willing to share quarterly? What you have compiled would be a brilliant way to track the ASX MC industry and progress of each company. Thanks again 

Geez isn't EXL a nice looking graph, Might be a hype phase based on Hemp/CBD legislation changes in the US however their earnings potential looks Strong.

Shows the potential Medlab is in for once sales increase this year and next.

Accumulation phase nearing a close this year. Maybe few more shoves down during 1st and 2nd quarter 2019 just to remove the remaining dogged early investors.

Investors that are wise enough to see an emerging new trend will doubt themselves as market cycles shift from the Hype phase to the Real Market Potential stage. Medlab appears in a good space. Cash starting to come in with potential earnings growth looking good as the distribution network grows and there appears to be minimal excessive dilution opposed to other MC stocks I follow.

Not ashamed to say I am very bullish on MC as a whole but also very sceptical surrounding the quality of MC companies out there. Only a few will really excel and those companies will have sound scientific research into areas of great public demand complimented with good management and sounds sales for existing products.

Above is not an endorsement to invest and I'm willingly sharing my opinion to engage others in constructive discussions. Alternate views welcome.